I love to talk about real estate to my friends and family. But each time, in the middle of the conversation, the same words come up: “risky”, “complex”, “uncertain”, “time consuming”… What if all this were about to change thanks to technology? Here are three areas where digital is dusting off real estate. Online Tools and Mortgage Simulators Online simulators are a down-to-earth living example … Continue reading When technology dusts off real estate
As the first bell-whether company to report, Alcoa Inc (NYSE:AA) said Q1 came in at a loss of $(0.16)/share. Excluding $276 million in special charges (from smelter and rolling mill capacity reductions), operating earnings for the metals and mining company were $0.09 (versus the street at $0.05). The delta versus analyst estimates came from strong performance in the alumina segment; primary metals also came in better … Continue reading Alcoa Inc (NYSE:AA) Posts Strong First Quarter Results
General Electric Company (NYSE:GE) was the target of some unusual options trading activity on Thursday. Traders bought 67,427 call options on the stock, Stock Ratings News reports. General Electric Company (NYSE:GE) has been the subject of a number of recent research reports. Analysts at TheStreet reiterated a “buy” rating on shares of General Electric Company (NYSE:GE) in a research note. General Electric Company (NYSE:GE) stock … Continue reading NYSE Movers: General Electric Company (NYSE:GE), Alcoa Inc (NYSE:AA), AT&T Inc. (NYSE:T), Ford Motor Company (NYSE:F)
Texas Industries (TXI) shares edged up Thursday, after the supplier of construction materials late Wednesday reported a narrower-than-expected adjusted loss for its fiscal Q3 on revenue that topped the Street view. For the quarter ended Feb. 28, the company posted a net loss of $21.8 million, or $0.76 per share, compared with a year-earlier net loss of $5.8 million, or $0.21 per share. Excluding one-time … Continue reading Texas Industries Edges Up on Narrower-Than-Expected Adjusted Q3 Loss
Congress jumped into the health care game (again) by “complaining” that Gilead Sciences, Inc. (NASDAQ:GILD)’s hepatitis drug was priced too high. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 3.92% in last session and finished the day at $73.64. Traded volume was 19.50million shares in the last session and the average volume of the stock remained 13.29million shares. The beta of the stock remained 0.55. Gilead … Continue reading Healthcare Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Bristol-Myers Squib (NYSE:BMY), Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
ARM Holdings reported strong third-quarter earnings and gave investors a solid, but not spectacular, fourth-quarter outlook that was relatively in line with our expectations. We will maintain our moat rating for ARM but may raise our fair value estimate by about 10%. Nonetheless, we still believe the company’s stock price reflects overly optimistic assumptions about long-term royalty growth, particularly from PCs and servers. ARM’s revenue … Continue reading ARM Holdings in Line to Meet Full Year Guidance After Solid Quarter
